Literature DB >> 12779075

Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions.

A Zullo1, C Hassan, S Morini.   

Abstract

Helicobacter pylori infection could play a role in different clinical alterations observed in cirrhosis, from gastroduodenal lesions to hepatic encephalopathy. Although its prevalence in cirrhotics is similar to that in controls, H. pylori infection is responsible for the increased prevalence of peptic ulcer observed in these patients. The ammonia production by H. pylori urease does not seem to increase blood ammonia levels during cirrhosis, indicating that its role in hepatic encephalopathy could be marginalized in clinical practice. Dual and triple therapies have been shown to be equally effective for H. pylori eradication in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12779075     DOI: 10.1016/s1590-8658(03)00029-x

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  12 in total

Review 1.  Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review.

Authors:  M Kalafateli; C K Triantos; V Nikolopoulou; A Burroughs
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Usefulness of the immunological rapid urease test for detection of Helicobacter pylori in patients who are reluctant to undergo endoscopic biopsies.

Authors:  Hajime Isomoto; Kaoru Kawazoe; Kenichiro Inoue; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.199

3.  Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments.

Authors:  Fiona V Bϋdingen; Daniel Gonzalez; Amelia N Tucker; Hartmut Derendorf
Journal:  Ther Adv Infect Dis       Date:  2014-02-01

Review 4.  Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice.

Authors:  Rafael F Perini; Paula R S Camara; Jose G P Ferraz
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-02-03

5.  Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm?

Authors:  Bauyrzhan Aituov; Assem Duisembekova; Assel Bulenova; Kenneth Alibek
Journal:  Infect Agent Cancer       Date:  2012-08-08       Impact factor: 2.965

6.  Helicobacter pylori and portal hypertensive gastropathy: any new information?

Authors:  Angelo Zullo; Cesare Hassan; Lorenzo Ridola; Vincenzo De Francesco
Journal:  Ann Gastroenterol       Date:  2014

Review 7.  Management of portal hypertensive gastropathy and other bleeding.

Authors:  Woo Jin Chung
Journal:  Clin Mol Hepatol       Date:  2014-03-26

8.  Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis.

Authors:  Dong Joon Kim; Hak Yang Kim; Sung Jung Kim; Tae Ho Hahn; Myoung Kuk Jang; Gwang Ho Baik; Jin Bong Kim; Sang Hoon Park; Myung-Seok Lee; Choong Kee Park
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 3.165

9.  Association of Helicobacter pylori with elevated blood ammonia levels in cirrhotic patients: a meta-analysis.

Authors:  Hai-Xing Jiang; Shan-Yu Qin; Zhi-gang Min; Ming-Zhi Xie; Tao Lin; Bang-Li Hu; Xiao-Yun Guo
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

10.  Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study.

Authors:  Ahmed Abdel-Razik; Nasser Mousa; Rania Elhelaly; Rasha Elzehery; Ahmad S Hasan; Mostafa Abdelsalam; Ahmed Salah Seif; Ahmed M Tawfik; Niveen El-Wakeel; Waleed Eldars
Journal:  Front Med (Lausanne)       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.